The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

BioBanking - The Holy Grail of novel drug and diagnostic developments?

På svenska

Author

Summary, in English

ABSTRACT: The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.

Publishing year

2011

Language

English

Publication/Series

Journal of Clinical Bioinformatics

Volume

1

Issue

1

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Medical Engineering

Status

Published

ISBN/ISSN/Other

  • ISSN: 2043-9113